AzTrials
AzTrials

Gall Bladder DiseaseGBSACWCHANCT03533322

Gall Bladder Status Among Children With Chronic Haemolytic Anemia

An observational study of Gall Bladder Disease, run by Assiut University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Gall bladder status among children with chronic haemolytic anemia attending to Assuit University Children Hospital. Hemolysis is defined as the premature destruction of red blood cells (RBCs) (a shortened RBC life span). Anemia results when the rate of destruction exceeds the capacity of the marrow to produce RBCs. Read more about this study

Who is it for?
Ages 1 year to 18 years
Conditions the study is for
Gall Bladder Disease
How many people
50 participants
Where
No sites listed yet
Study dates
1 Oct 2018to 1 Oct 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: All patients admitted to Assiut university children Hospital 1 year study * 2.4.4 -Study tools (in detail, e.g., lab methods, instruments, steps, chemicals, …): Full clinical history including (age of onset of chronic haemolytic anemia- type of chronic haemolytic anemia -frequency of blood transfusion - use of hydroxy urea - splenectomy or not- frequency of admission) * Detailed clinical examination * Abdominal ultrasound * Plain KUB (kidney ureter bladder) x-rayif radiopaque stone. * Compelete blood count * Liver function test * C- reactive protein

Who may be able to join

  • children between 1 :18 years known to have chronic haemolytic anemia.

Who cannot join

  • children below 1 year and above 18 years children had past history of cholecystectomy

Trial locations and contacts

No sites are listed yet.

shohnda nazeir, master contact

01064195028

shahdmohammed2060@gmail.com

About this study

Official title: Gall Bladder Status Among Children With Chronic Haemolytic Anemia Attending to Assuit University Children Hospital

Gall bladder status among children with chronic haemolytic anemia attending to Assuit University Children Hospital.

Hemolysis is defined as the premature destruction of red blood cells (RBCs) (a shortened RBC life span). Anemia results when the rate of destruction exceeds the capacity of the marrow to produce RBCs. Normal RBC survival time is 110-120 days (half-life: 55-60 days), and thus, approximately 0.85% of the most senescent RBCs are removed and replaced each day.

Read more

Patients with chronic haemolytic anemia are subjected to many complications of chronic haemolytic anemia e.g anemic heart failure, complications of blood transfusion as hepatitis and AIDS, hypersplenism, haemosiderosis ,among them there is incidence of gallbladder stone formation.

This work aims to a) to determine the prevalence of gall bladder diseases among patient with chronic haemolytic anemia.

  1. to determine the risk factors of gall bladder diseases among patients with chronic haemolytic anemia.
Read the detailed description

Gall bladder status among children with chronic haemolytic anemia attending to Assuit University Children Hospital Hemolysis is defined as the premature destruction of red blood cells (RBCs) (a shortened RBC life span). Anemia results when the rate of destruction exceeds the capacity of the marrow to produce RBCs. Normal RBC survival time is 110-120 days (half-life: 55-60 days), and thus, approximately 0.85% of the most senescent RBCs are removed and replaced each day.(1) They may be classified according to the means of hemolysis, being either intrinsic in cases where the cause is related to the red blood cell (RBC) itself, defects of red blood cell membrane production (as in hereditary spherocytosis and hereditary elliptocytosis), defects in hemoglobin production (as in thalassemia, sickle-cell disease and congenital dyserythropoietic anemia), defective red cell metabolism (as in glucose-6-phosphate dehydrogenase deficiency and pyruvate kinase deficiency). or extrinsic in cases where factors external to the RBC dominate, acquired hemolytic anemia may be caused by immune-mediated causes, drugs and other miscellaneous causes. Patients with chronic haemolytic anemia are subjected to many complications of chronic haemolytic anemia e.g anemic heart failure, complications of blood transfusion as hepatitis and AIDS, hypersplenism, haemosiderosis ,among them there is incidence of gallbladder stone formation.(2) The gallbladder is a small pouch that sits just under the liver. The gallbladder stores bile produced by the liver. After meals, the gallbladder is empty and flat, like a deflated balloon. Before a meal, the gallbladder may be full of bile and about the size of a small pear. In response to signals, the gallbladder squeezes stored bile into the small intestine through a series of tubes called ducts. Bile helps digest fat.(3) Diseases affecting gall bladder in children as:a)Gallstones (cholelithiasis) for unclear reasons, substances in bile can crystallize in the gallbladder, forming gallstones which is common and usually harmless, gallstones can sometimes cause pain, nausea, or inflammation. b)Cholecystitis( Infection of the gallbladder), often due to a gallstone in the gallbladder. Cholecystitis causes severe pain and fever, and can require surgery when infection continues or recurs.c) Gallstone pancreatitis: An impacted gallstone blocks the ducts that drain the pancreas. Inflammation of the pancreas results, a serious condition.(4) While problems associated with the gallbladder are rare in children, almost 50 percent of children have gallstones. Many of them--between 80 percent and 90 percent--have no symptoms. However, even small stones in small children can cause problems , Gallstones are mainly categorized in three groups of cholesterol, pigment, and mixture, among which the mixture is more common. Imbalance in bile constituents,such as cholesterol,lecithin,andbilesalts,is the main cause of gallstone formation.(4-5) In children >70% of gallstones are the pigment type, these stones are mostly reported in cases with hemolytic disease, such as spherocytosis and sickle cell anemia, cirrhosis, bile tract infection, these stones are black-brown in color, the incidence increases progressively with age. In sickle-cell disease, the prevalence of pigment gallstones( was reported to be 10% to 15% in children under 10 years of age, it increased to 40% in those aged 10-18 years, and 50% in adults(6-7). The prevalence of gallstones in hereditary spherocytosis was 10% to 20% and in adult series it was 40%(7-8). In thalassemia, the reported figure is low (10% to 15%)(8-9). With longer survival of thalassemiapatients, higher prevalence of gallstones (50%) has been reported(9). The highest prevalence of gallstones have been reported in thalassemics with Gilbert's syndrome genotype(10). However, in a study on 64 patients with median age of 10 (range, 5 to 20) years with thalassemia major from Chandigarh, none had gallstones(11).

Risk factors

  1. Multiple blood transfusions: In patients who periodically receive blood transfusions, hemolysis of the transfused cells may supplement the chronic endogenous blood destruction as a factor in the formation of gallstones [11-12].
  2. High rates (20% by age of four years) of recurrent biliary tract obstruction in children with the sickle cell disease reported [13].
  3. Obesity: With the prevalence of childhood obesity on the rise, there is a need to be more aware of obesity-related comorbidity including gallbladder disease. No clear link between the diet and risk for cholelithiasis, though foods high in cholesterol and low in fiber may increase the risk [14].
  4. Inefficient and infrequent gallbladder contractions, which allow bile to sit in the gallbladder for long periods of time, resulting in an over concentrated bile that is conducive to stone formation [15].

1-Aim of the study:

  1. to determine the prevalence of gall bladder diseases among patient with chronic haemolytic anemia.
  2. to determine the risk factors of gall bladder diseases among patients with chronic haemolytic anemia. 2-Patients and methods: All cases included in the study will be subjected to:
  • Full clinical history including (age of onset of chronic haemolytic anemia- type of chronic haemolytic anemia -frequency of blood transfusion - use of hydroxy urea - splenectomy or not- frequency of admission)
  • Detailed clinical examination
  • Abdominal ultrasound
  • Plain KUB (kidney ureter bladder) x-ray if radiopaque stone.
  • Compelete blood count
  • Liver function test
  • C- reactive protein Type of study: cross- sectional study Site of the study: Haematology ;general surgery units and out patient clinics ;emergency unit at Assuit university children hospital. Duration of the study: one year Inclusion crieteria: children between 1 :18 years known to have chronic haemolytic anemia. Exclusion crieteria: children below 1 year and above 18 years children had past history of cholecystectomy Data analysis : Data will be processed and analyzed using SPSS software and the results will be processed in tables and figures . Ethical consideration:
  • Reviewing the proposal will be carried out before starting via the ethical committee of assuit faculty of medicine.
  • The aim of the study will be explained to each patient before beginning of the process,written consent will be obtained from those who welcome to participate in the study.
  • Privacy and confidentiality of all data will be assur
Medical subject headings
Gallbladder Diseases

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. prevelance of gall bladder diseases in children with chronic hemolytic syndrome

    gall bladder diseases

    Measured: one year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 May 2018
  2. Study start1 Oct 2018 (estimated)
  3. Primary completion1 Oct 2019 (estimated)
  4. Study completion1 Oct 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03533322
Sponsor's protocol ID
gallbladderstatusinchhemlytic
Acronym
GBSACWCHA
Status last verified
May 2018
First submitted
11 May 2018
Last updated
31 Jul 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Gall Bladder Disease, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 31 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact shohnda nazeir, master (01064195028, shahdmohammed2060@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

prevelance of gall bladder diseases in children with chronic hemolytic syndrome (time frame: one year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jul 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in